Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-024443
Filing Date
2021-12-02
Accepted
2021-12-02 16:43:17
Documents
2
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163848137519815.html 3  
1 FORM 3 wf-form3_163848137519815.xml 3 1691
2 POWER OF ATTORNEY, EXHIBIT 24.1 CAROLINE LEVY chromadex-formsection16pow.htm EX-24 7137
  Complete submission text file 0001628280-21-024443.txt   10320
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 2424 N FEDERAL HIGHWAY SUITE 208 BOCA RATON FL 33431
Business Address
Levy Caroline S (Reporting) CIK: 0001820042 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37752 | Film No.: 211467225